ABMC NEWS

FDA Grants CLIA Waiver to ABMC for Its Drug Test
August 27, 2008

<< MORE COMPANY NEWS >>

Rapid Reader® v440/441
Software Update available.


FSS Contract GS-07F-0277L

ISO 13485 Certified


 

 


American Bio Medica Corporation (NASDAQ: ABMC) is a biotechnology company that develops, manufactures and markets accurate, cost-effective immunoassay diagnostic test kits, including some of the world's most effective point-of-collection tests for drugs of abuse.

Rapid ONE®Rapid Drug Screen®Rapid TEC®RDS® InCup®OralStat®Rapid TOX®Rapid Reader®

Rapid Drug Screen® (RDS®) is a multi-drug test kit including a collection cup with a temperature strip and test card that detects two to ten drugs of abuse in urine. Simply insert the test card through the slotted lid and read the results once the control line forms, typically in 3-5 minutes.